Cargando…

Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study

BACKGROUND: We compared all-cause mortality, major macrovascular events (MACE) and diabetes-related hospitalizations in T2DM-incident patients newly treated with metformin (MET) versus sulphonylureas (SU) monotherapy and in T2DM-prevalent patients newly treated with MET+SU versus MET+DPP4-inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilke, Thomas, Mueller, Sabrina, Groth, Antje, Berg, Bjoern, Hammar, Niklas, Tsai, Katherine, Fuchs, Andreas, Stephens, Stephanie, Maywald, Ulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969981/ https://www.ncbi.nlm.nih.gov/pubmed/27486568 http://dx.doi.org/10.1186/s40200-016-0251-9

Ejemplares similares

Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis
por: Wilke, Thomas, et al.
Publicado: (2015)

Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus
por: Wilke, Thomas, et al.
Publicado: (2015)

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset
por: Mueller, Sabrina, et al.
Publicado: (2018)

Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients
por: Müller, Sabrina, et al.
Publicado: (2017)

Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study
por: van Dalem, Judith, et al.
Publicado: (2016)

Primary data, claims data, and linked data in observational research: the case of COPD in Germany
por: Mueller, Sabrina, et al.
Publicado: (2018)

Optimal utilisation of sulphonylureas in resource-constrained settings
por: Naidoo, Poobalan, et al.
Publicado: (2014)

Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC‐39)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

Variation in KCNQ1 is associated with therapeutic response to sulphonylureas
por: Schroner, Zbynek, et al.
Publicado: (2011)

Neonatal Diabetes Caused by Activating Mutations in the Sulphonylurea Receptor
por: Proks, Peter
Publicado: (2013)

Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS)
por: Ghiani, Marco, et al.
Publicado: (2023)

Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
por: Lukashevich, V, et al.
Publicado: (2014)

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
por: Chacra, A R, et al.
Publicado: (2009)

Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
por: Davies, M J, et al.
Publicado: (2012)

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
por: Wilding, J P H, et al.
Publicado: (2013)

Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin‐naïve people with Type 2 diabetes: the DUAL IV trial
por: Rodbard, H. W., et al.
Publicado: (2016)

Sulphonylurea Usage in Melioidosis Is Associated with Severe Disease and Suppressed Immune Response
por: Liu, Xiang, et al.
Publicado: (2014)

What’s next after metformin? focus on sulphonylurea: add-on or combination therapy
por: Lim, Phei C., et al.
Publicado: (2015)

Binding of sulphonylureas to plasma proteins – A K(ATP) channel perspective
por: Proks, Peter, et al.
Publicado: (2018)

Modern sulphonylureas and cardiovascular adverse effects: Will CAROLINA put an end to the controversy?
por: John, Mathew, et al.
Publicado: (2020)

Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus
por: Fournier, Marie, et al.
Publicado: (2014)

Single Nucleotide Polymorphisms Associated with Metformin and Sulphonylureas’ Glycaemic Response among South African Adults with Type 2 Diabetes Mellitus
por: Masilela, Charity, et al.
Publicado: (2021)

Identifying the Causes Increasing the Risk of Non-Adherence in Adult Patients with Asthma: An Analysis Combining Patient Survey Data with German Claims Data
por: Müller, Sabrina, et al.
Publicado: (2021)

Molecular Classification of Pesticides Including Persistent Organic Pollutants, Phenylurea and Sulphonylurea Herbicides
por: Torrens, Francisco, et al.
Publicado: (2014)

Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
por: Mevius, Antje, et al.
Publicado: (2022)

Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study
por: Giorda, Carlo Bruno, et al.
Publicado: (2020)

Epidemiology, real-world treatment and mortality of patients with status epilepticus in Germany: insights from a large healthcare database
por: Mevius, Antje, et al.
Publicado: (2023)

FRI651 Usage Of Modern Sulphonylureas And Metformin Fixed Dose Combination (fdc) In Type 2 Diabetes Mellitus (t2dm) Patients With Established Complications
por: M, Aushili, et al.
Publicado: (2023)

Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study
por: Wilke, Thomas, et al.
Publicado: (2022)

Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis
por: Salvo, Francesco, et al.
Publicado: (2016)

Molecular action of sulphonylureas on K(ATP) channels: a real partnership between drugs and nucleotides
por: de Wet, Heidi, et al.
Publicado: (2015)

Risk of a first‐ever acute myocardial infarction and all‐cause mortality with sulphonylurea treatment: A population‐based cohort study
por: van Dalem, Judith, et al.
Publicado: (2017)

Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin
por: Seino, Y, et al.
Publicado: (2014)

Association of CYP2C9*2 Allele with Sulphonylurea-Induced Hypoglycaemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population
por: Jan, Asif, et al.
Publicado: (2023)

P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data
por: Pacis, S, et al.
Publicado: (2022)

POSA32 Early COVID-19 Pandemic in Germany: Patient Characteristics and Clinical Outcomes
por: Pacis, S, et al.
Publicado: (2022)

POSA52 A Year-on-Year Comparison Overall German Healthcare Resource Utilization in COVID Versus Non-COVID Times: A German Claims Data Analysis
por: Mevius, A, et al.
Publicado: (2022)

EPH35 Post-COVID Conditions in Hospitalized COVID-19 Patients in Germany
por: Pacis, S, et al.
Publicado: (2022)

EPH144 The Impact of COVID-19 Pandemic on the Detection and Management of Cancer: A German Claims Data Analysis
por: Mevius, A, et al.
Publicado: (2022)

Switching to Sulphonylureas in Children With iDEND Syndrome Caused by KCNJ11 Mutations Results in Improved Cerebellar Perfusion
por: Fendler, Wojciech, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o8785g819a7s0uru645g9s723j